Anastrozole Tablet
Product Images NDC 72789-008

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 72789-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789008 Label (72789008)

Anastrozole USP 1 mg oral tablets label from PD-Rx Pharmaceuticals, Inc., showing a 90-tablet package. The label includes the NDC 72789-008-90, lot number F20A17, and expiration date 06/2022. There is a warning to keep the product out of reach of children and a note to consult the package insert for dosage and storage instructions. The label also has a barcode and the company address in Oklahoma City, OK.*

FDA Label Image

Figure 1 (Anastrozole Fig1)

A Kaplan-Meier survival curve graph showing the proportion of patients alive and disease-free over time in months for randomized treatments with anastrozole and tamoxifen. The x-axis represents disease-free survival in months, and the y-axis shows the proportion alive and disease-free. Patient numbers at risk at various months are listed below for both treatments.*

FDA Label Image

Figure 2 (Anastrozole Fig2)

A line graph comparing disease-free survival over 90 months for patients treated with anastrozole versus tamoxifen. The y-axis shows the proportion alive and disease-free, ranging from 0.0 to 1.0, while the x-axis represents time in months. Both treatments show a decline in survival proportion, with data on patient numbers at risk provided below the graph.*

FDA Label Image

Figure 3 (Anastrozole Fig3)

A Kaplan-Meier curve graph comparing progression-free survival over time (in months) for patients receiving treatment with Anastrozole versus Tamoxifen. The y-axis represents the proportion of patients progression-free, and the x-axis shows time to event in months, up to 120 months. The graph includes numbers of patients at risk at various time points below the x-axis.*

FDA Label Image

Figure 4 (Anastrozole Fig4)

A Kaplan-Meier curve chart comparing the proportion of event-free patients over time (in months) between two randomized treatments: Anastrozole and Tamoxifen. The vertical axis shows the proportion event-free, and the horizontal axis shows time to event up to 120 months. Patient risk numbers are listed below the time axis.*

FDA Label Image

Figure 5 (Anastrozole Fig5)

A Kaplan-Meier survival curve chart comparing the proportion of patients without disease progression over time (in months) between two randomized treatments: Anastrozole and Tamoxifen. The X-axis represents time to progression in months, and the Y-axis shows the proportion not progressing. The chart includes stepwise curves and a risk table below the X-axis showing patient counts at different time points for each treatment group.*

FDA Label Image

Figure 6 (Anastrozole Fig6)

A line graph depicting progression over time in months for randomized treatments with Anastrozole and Tamoxifen. The vertical axis represents the proportion not progressed, ranging from 0.0 to 1.0, while the horizontal axis shows time in months up to 42. Two lines compare the progression for each treatment over time.*

FDA Label Image

Chemical Structure For Anastrozole (Anastrozole Str)

Chemical structure of anastrozole, showing its molecular framework with nitrogen-containing rings and cyanide groups consistent with the active ingredient anastrozole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.